300142-基本财务实时评分详情
沃森生物300142基本财务实时评分详情
更新时间:2021-05-06 00:00:01
股票代码
300142
当期评分
股票名称
沃森生物
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)-0.04240.04030.0730.0730.073
销售净利润率(%)120.891617.314734.561634.561634.5616
销售毛利率(%)79.256978.945485.627785.627785.6277
净资产收益率(%)22.872.927.547.547.54
营业增长率(%)31.541427.549996.463296.463296.4632
净利润增长率(%)---81.7317237.6624237.6624237.6624
每股收益(%)0.68050.09230.04-0.01180.2832
现金流量比率(%)-4.24725.6976-3.9531-5.14888.1598
三项费用比重(%)56.389959.771650.565570.104345.7305
每股净资产(¥)2.97513.16453.30673.1443.7425
流动比率(%)2.6953.16383.64563.20822.9799
速动比率(%)2.54112.87623.18592.82352.6578
现金比率(%)161.7584218.77217.0725207.3934207.3934
总资产利润率(%)16.20822.72381.2835-0.25866.9532
主营利润比重%58.8681385.7528383.866-416.2326212.3688
应收账款(万元)43,748.4151,284.4165,430.5845,035.87129,406.06
应收票据(万元)15.73--------
预付款项(万元)3,660.401,826.635,249.612,147.592,057.11
存货(万元)23,628.2931,304.8941,223.8439,510.2544,503.59
在建工程(万元)55,402.9569,922.6468,232.4662,763.4365,220.20
应付款项(万元)25,179.4727,673.9930,228.5230,527.7734,397.69
长期借款(万元)----------
未分配利润(万元)43,453.7350,952.2457,101.3449,140.4791,412.83
商誉(万元)3,365.763,365.763,365.763,365.763,365.76
流动资产(万元)309,805.31357,400.43392,679.73361,952.36444,071.56
流动负债(万元)153,581.32108,846.5489,666.48102,700.79138,162.84
沃森生物300142评分结果
75.76分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006